The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.
about
BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.Cancer immunotherapy beyond immune checkpoint inhibitors.Novel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignancies.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer
P2860
The emerging role of anti-CD25 directed therapies as both immune modulators and targeted agents in cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The emerging role of anti-CD25 ...... and targeted agents in cancer.
@en
The emerging role of anti-CD25 ...... and targeted agents in cancer.
@nl
type
label
The emerging role of anti-CD25 ...... and targeted agents in cancer.
@en
The emerging role of anti-CD25 ...... and targeted agents in cancer.
@nl
prefLabel
The emerging role of anti-CD25 ...... and targeted agents in cancer.
@en
The emerging role of anti-CD25 ...... and targeted agents in cancer.
@nl
P2860
P356
P1476
The emerging role of anti-CD25 ...... and targeted agents in cancer.
@en
P2093
Michael J Flynn
P2860
P356
10.1111/BJH.14770
P407
P577
2017-05-30T00:00:00Z